Bont
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
117 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Muscle spasticity | D009128 | HP_0001257 | — | — | 1 | 2 | 2 | 28 | 33 |
| Dystonia | D004421 | HP_0001332 | G24 | 1 | 2 | — | 2 | 12 | 16 |
| Dystonic disorders | D020821 | — | G24 | 1 | 2 | — | 2 | 10 | 14 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | 3 | 9 | 13 |
| Cerebral palsy | D002547 | — | G80 | — | 2 | 2 | 1 | 7 | 12 |
| Torticollis | D014103 | HP_0000473 | F45.8 | — | 1 | — | 2 | 6 | 9 |
| Interstitial cystitis | D018856 | EFO_1000869 | N30.1 | 1 | 4 | — | 1 | — | 6 |
| Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | — | 3 | — | 1 | 2 | 6 |
| Paralysis | D010243 | HP_0003470 | — | — | — | 2 | 1 | 2 | 5 |
| Clostridium botulinum | D003014 | NCBITaxon_1491 | — | 1 | — | — | 1 | 1 | 3 |
Show 8 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic hyperplasia | D011470 | EFO_0000284 | N40 | 2 | 1 | 1 | — | — | 4 |
| Hyperplasia | D006965 | EFO_0000536 | — | 2 | 1 | 1 | — | — | 4 |
| Syndrome | D013577 | — | — | 1 | 2 | 1 | — | 1 | 4 |
| Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | 1 | 2 | 1 | — | — | 2 |
| Hypertrophic cicatrix | D017439 | — | L91.0 | — | 1 | 1 | — | — | 1 |
| Cicatrix | D002921 | HP_0100699 | L90.5 | — | 1 | 1 | — | — | 1 |
| Low back pain | D017116 | HP_0003419 | M54.5 | — | — | 1 | — | — | 1 |
| Back pain | D001416 | HP_0003418 | M54 | — | — | 1 | — | — | 1 |
| Urinary retention | D016055 | HP_0000016 | R33 | — | 1 | 1 | — | — | 1 |
| Hereditary hemorrhagic telangiectasia | D013683 | — | I78.0 | — | 1 | 1 | — | — | 1 |
Show 6 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cystitis | D003556 | EFO_1000025 | N30 | 1 | 4 | — | — | — | 5 |
| Tremor | D014202 | HP_0001337 | R25.1 | — | 2 | — | — | 2 | 4 |
| Neuralgia | D009437 | EFO_0009430 | — | — | 2 | — | — | 1 | 3 |
| Pelvic pain | D017699 | — | — | 2 | 1 | — | — | 1 | 3 |
| Migraine disorders | D008881 | EFO_0003821 | G43 | — | 2 | — | — | — | 2 |
| Traumatic brain injuries | D000070642 | — | S06 | — | 1 | — | — | 1 | 2 |
| Brain injuries | D001930 | — | S06.9 | — | 1 | — | — | 1 | 2 |
| Essential tremor | D020329 | EFO_0003108 | G25.0 | — | 1 | — | — | 1 | 2 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | 1 | — | — | 1 | 2 |
| Chronic disease | D002908 | — | — | — | 1 | — | — | — | 1 |
Show 15 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Botulism | D001906 | EFO_0005542 | A05.1 | 2 | — | — | — | 1 | 3 |
| Chronic pain | D059350 | HP_0012532 | — | 1 | — | — | — | 2 | 3 |
| Pelvic floor disorders | D059952 | — | — | 1 | — | — | — | 1 | 2 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
| Lower urinary tract symptoms | D059411 | EFO_0008008 | — | 1 | — | — | — | — | 1 |
| Facial pain | D005157 | — | R51.9 | 1 | — | — | — | — | 1 |
| Facial neuralgia | D005156 | EFO_0009380 | 351.8 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hemiplegia | D006429 | HP_0011099 | G81.0 | — | — | — | — | 2 | 2 |
| Bruxism | D002012 | — | F45.8 | — | — | — | — | 2 | 2 |
| Wounds and injuries | D014947 | — | T14.8 | — | — | — | — | 1 | 1 |
| Treatment outcome | D016896 | — | — | — | — | — | — | 1 | 1 |
| Skin abnormalities | D012868 | HP_0000951 | Q82.9 | — | — | — | — | 1 | 1 |
| Muscle tonus | D009129 | — | — | — | — | — | — | 1 | 1 |
| Physical therapy modalities | D026741 | — | — | — | — | — | — | 1 | 1 |
| Urinary bladder diseases | D001745 | — | N32.9 | — | — | — | — | 1 | 1 |
| Dysphonia | D055154 | — | R49.0 | — | — | — | — | 1 | 1 |
| Hoarseness | D006685 | HP_0001609 | R49.0 | — | — | — | — | 1 | 1 |
Show 14 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | — |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use